Latest News

Lifileucel treats advanced melanoma by harvesting, expanding, and reinfusing a patient's own tumor-fighting immune cells.

New Yale University research offers reassurance for pregnant patients and their clinicians, though evidence of lasting structural damage remains a concern.

Tracking PDUFA decisions and early planning can lead to safe, rapid access to new medications for patients.

Dupilumab becomes the first biologic approved for children aged 2 to 11 years with uncontrolled chronic spontaneous urticaria, marking a significant expansion in treatment options and pharmacist-led care considerations.

Performing medication reconciliations and assessing for drug interactions are examples of strategies to prevent medication errors.

A postdischarge diabetes follow-up showed me how pharmacists prevent harm by catching omissions, simplifying plans, and using technology to restore patient confidence.

Ecopipam reduces Tourette tic relapse risk by approximately 50% with durable control and no movement-related adverse effects.

AACR data show tumor molecular profiling finds actionable PIK3CA in breast and colorectal cancer, while ctDNA adds real-time monitoring in oncology.

Pharmacists play a crucial role in evaluating 505(b)(2) drugs—from ensuring oncology therapeutic equivalence to improving access and outcomes.

Global trade disruptions and reliance on overseas manufacturing could contribute to future drug shortages, highlighting the need for proactive planning and supply chain resilience across pharmacy settings.

National certification, advanced specialization, and informatics enhance career longevity and patient safety

Phase 3 data show quarterly cemdisiran injections improve gMG symptoms, either and matches or outperforms all study end points compared to combination therapy.

Make sure your communication is respectful, personalized, and strategic for maximum benefit.

FDA approval expands teplizumab-mzwv to patients 1 year and older, helping delay type 1 diabetes onset for children with stage 2 diabetes.

Cultivating balance and well-being is essential to prevent burnout and foster resilience for future practice.

Phase 3 METEOROID shows IL-6 blocker satralizumab cuts MOGAD relapses 68%, with rapid onset and placebo-like safety.

The approval of doravirine and islatravir marks a new 2-drug, once-daily oral option for HIV-1 management, with implications for treatment simplification, adherence, and pharmacist-led antiretroviral care.

PTCB credentialing elevates pharmacy technicians’ safety and career commitment, boosts patient trust, and enables efficient delegation—helping reduce medication errors in modern pharmacies.

Ferric carboxymaltose is effective and guideline-endorsed, yet underutilized due to high cost and system-level barriers.

A PharmD diploma is available to BSPh graduates based on time in education and training, licensure by examination, and an evolving professional curriculum.

Research presented at the American Association for Cancer Research Annual Meeting shows personalized mRNA vaccine immunotherapy targets pancreatic cancer tumor neoantigens, sparking durable T-cell responses and boosting survival in a phase 1 clinical trial.